Cargando…

Combining histone deacetylase inhibitors with MDA-7/IL-24 enhances killing of renal carcinoma cells

In the present study we show that histone deacetylase inhibitors (HDACIs) enhance the anti-tumor effects of melanoma differentiation associated gene-7/interleukin 24 (mda-7/IL-24) in human renal carcinoma cells. Similar data were obtained in other GU tumor cells. Combination of these two agents resu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hamed, Hossein A, Das, Swadesh K, Sokhi, Upneet K, Park, Margaret A, Cruickshanks, Nichola, Archer, Kellie, Ogretmen, Besim, Grant, Steven, Sarkar, Devanand, Fisher, Paul B, Dent, Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Landes Bioscience 2013
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3925659/ https://www.ncbi.nlm.nih.gov/pubmed/24025359 http://dx.doi.org/10.4161/cbt.26110

Ejemplares similares

Human Polynucleotide Phosphorylase (hPNPase(old-35)): An evolutionary conserved gene with an expanding repertoire of RNA degradation functions
por: Das, Swadesh K., et al.
Publicado: (2010)

Identification of Genes Potentially Regulated by Human Polynucleotide Phosphorylase (hPNPase(old-35)) Using Melanoma as a Model
por: Sokhi, Upneet K., et al.
Publicado: (2013)

Mechanism of internalization of MDA-7/IL-24 protein and its cognate receptors following ligand-receptor docking
por: Pradhan, Anjan K., et al.
Publicado: (2019)

Nexavar/Stivarga and Viagra Interact to Kill Tumor Cells
por: Tavallai, Mehrad, et al.
Publicado: (2015)

Regulation of neuroblastoma migration, invasion and in vivo metastasis by genetic and pharmacological manipulation of MDA-9/Syntenin
por: Bhoopathi, Praveen, et al.
Publicado: (2019)

Histone deacetylase inhibitors restore toxic BH3 domain protein expression in anoikis-resistant mammary and brain cancer stem cells, thereby enhancing the response to anti-ERBB1/ERBB2 therapy
por: Cruickshanks, Nichola, et al.
Publicado: (2013)

Suppression of Her2/Neu mammary tumor development in mda-7/IL-24 transgenic mice
por: Li, You-Jun, et al.
Publicado: (2015)

MDA-9/Syntenin (SDCBP) Is a Critical Regulator of Chemoresistance, Survival and Stemness in Prostate Cancer Stem Cells
por: Talukdar, Sarmistha, et al.
Publicado: (2019)

Novel function of MDA-9/Syntenin (SDCBP) as a regulator of survival and stemness in glioma stem cells
por: Talukdar, Sarmistha, et al.
Publicado: (2016)

MDA-9/Syntenin (SDCBP) modulates small GTPases RhoA and Cdc42 via transforming growth factor β1 to enhance epithelial-mesenchymal transition in breast cancer
por: Menezes, Mitchell E., et al.
Publicado: (2016)

MDA-7/IL-24 functions as a tumor suppressor gene in vivo in transgenic mouse models of breast cancer
por: Menezes, Mitchell E., et al.
Publicado: (2015)

Insights into the Mechanisms of Action of MDA-7/IL-24: A Ubiquitous Cancer-Suppressing Protein
por: Modi, Jinkal, et al.
Publicado: (2021)

Knockout of MDA-9/Syntenin (SDCBP) expression in the microenvironment dampens tumor-supporting inflammation and inhibits melanoma metastasis
por: Das, Swadesh K., et al.
Publicado: (2016)

AEG-1–AKT2: A novel complex controlling the aggressiveness of glioblastoma
por: Emdad, Luni, et al.
Publicado: (2015)

Metabolism of Histone Deacetylase Proteins Opsonizes Tumor Cells to Checkpoint Inhibitory Immunotherapies
por: Dent, Paul, et al.
Publicado: (2019)

Histone deacetylase inhibitor AR-42 and achiral analogues kill malaria parasites in vitro and in mice
por: Chua, Ming Jang, et al.
Publicado: (2021)

Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
por: Phimmachanh, Monica, et al.
Publicado: (2020)

Histone Deacetylase Inhibitors Enhance CD4 T Cell Susceptibility to NK Cell Killing but Reduce NK Cell Function
por: Pace, Matthew, et al.
Publicado: (2016)

Beyond Histone and Deacetylase: An Overview of Cytoplasmic Histone Deacetylases and Their Nonhistone Substrates
por: Yao, Ya-Li, et al.
Publicado: (2011)

Regulation of PP2A by Sphingolipid Metabolism and Signaling
por: Oaks, Joshua, et al.
Publicado: (2015)

The Role of Ceramide Metabolism and Signaling in the Regulation of Mitophagy and Cancer Therapy
por: Sheridan, Megan, et al.
Publicado: (2021)

Potentiating Oncolytic Virus-Induced Immune-Mediated Tumor Cell Killing Using Histone Deacetylase Inhibition
por: Jennings, Victoria A., et al.
Publicado: (2019)

Histone deacetylase enzymes and selective histone deacetylase inhibitors for antitumor effects and enhancement of antitumor immunity in glioblastoma
por: Yelton, Caleb J., et al.
Publicado: (2018)

Regulation of Immune Responses by Histone Deacetylase Inhibitors
por: Licciardi, Paul V., et al.
Publicado: (2012)

Histone Deacetylases and Histone Deacetylase Inhibitors: Molecular Mechanisms of Action in Various Cancers
por: Sanaei, Masumeh, et al.
Publicado: (2019)

Cytotoxic Activity of the Histone Deacetylase 3-Selective Inhibitor Pojamide on MDA-MB-231 Triple-Negative Breast Cancer Cells
por: Luparello, Claudio, et al.
Publicado: (2019)

When to screen and not to screen
por: Cruickshanks, Nichola
Publicado: (2014)

Targeting histone deacetylases for the treatment of disease
por: Lawless, M W, et al.
Publicado: (2009)

Targeting Sphingolipid Metabolism as a Therapeutic Strategy in Cancer Treatment
por: Janneh, Alhaji H., et al.
Publicado: (2022)

The Histone Deacetylase Inhibitor JAHA Down-Regulates pERK and Global DNA Methylation in MDA-MB231 Breast Cancer Cells
por: Librizzi, Mariangela, et al.
Publicado: (2015)

Chemical Phylogenetics of Histone Deacetylases
por: Bradner, James E., et al.
Publicado: (2010)

Histone deacetylases in viral infections
por: Herbein, Georges, et al.
Publicado: (2010)

Butyrate Histone Deacetylase Inhibitors
por: Steliou, Kosta, et al.
Publicado: (2012)

Histone deacetylase signaling in cardioprotection
por: Lehmann, Lorenz H., et al.
Publicado: (2013)

Histone deacetylase 6 in cancer
por: Li, Ting, et al.
Publicado: (2018)

Histone deacetylase inhibitors (HDACIs): multitargeted anticancer agents
por: Ververis, Katherine, et al.
Publicado: (2013)

Histone deacetylase inhibitors suppress mutant p53 transcription via histone deacetylase 8
por: Yan, Wensheng, et al.
Publicado: (2012)

Histone deacetylase 9 regulates breast cancer cell proliferation and the response to histone deacetylase inhibitors
por: Lapierre, Marion, et al.
Publicado: (2016)

Dietary Folic Acid Alters Metabolism of Multiple Vitamins in a CerS6- and Sex-Dependent Manner
por: Barron, Keri, et al.
Publicado: (2021)

mTOR kinase inhibitors synergize with histone deacetylase inhibitors to kill B-cell acute lymphoblastic leukemia cells
por: Beagle, Brandon R., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_veet5t7r4tbf60k5hc89fq0tak